// App-Quantinova.ai

306 : Early Prediction of Human Renal Allograft Rejection (AR) by Inflammatory Transitional B Cells

Researchers

Presenter

  • A. Cherukuri

Principal Investigators

  • A. Sharma

  • R. Mehta

  • H. Sundaram

  • A. Salama

  • D. Rothstein

Medical Centers

  • Thomas E. Starzl Transplantation Institute, UPMC, Pittsburgh, PA

  • NCRI, London, United Kingdom

Locations

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Nephrology

Disease

  • Acute renal allograft rejection

Biomarkers

  • Peripheral blood mononuclear cell

  • Interleukin 10

Drug/Treatment

  • Interleukin-10

Outcome

  • N/A

Study Design

  • Observational

  • Multicenteric

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved